Rifampicin-Resistant Multidrug-Resistant Tuberculosis Cases in Selected Hospitals in Western Oromia, Ethiopia: Cross-Sectional Retrospective Study

References

• Kant S, Maurya AK, Kushwaha RA, et al. Multi-drug resistant tuberculosis: an iatrogenic problem. Biosci Trends. 2010;4(2):48–55.20448341
   PubMed Web of Science ®Google Scholar
• World Health Organization. New Technologies for TB Control: A Framework for Their Adoption, Introduction, and Implementation. Geneva: World Health Organization; 2007.
   Google Scholar
• Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis. 1998;79(1):3–29. doi:10.1054/tuld.1998.000210645439
   PubMedGoogle Scholar
• Herrera L, Jiménez S, Valverde A, et al. Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996–2001). Description of new mutations in the rpoB gene and review of the literature. Int J Antimicrob Agents. 2003;21(5):403–408. doi:10.1016/S0924-8579(03)00036-012727071
   PubMed Web of Science ®Google Scholar
• Fan XY, Hu ZY, Xu FH, et al. Rapid detection of rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis isolates in Shanghai by using the amplification refractory mutation system. J Clin Microbiol. 2003;41(3):993–997. doi:10.1128/JCM.41.3.993-997.200312624020
   PubMed Web of Science ®Google Scholar
• Braunwald E, Fauci AS, Kasper DL, et al. Harrison’s Principles of Internal Medicine. McGraw Hill; 2001.
   Google Scholar
• Purwar S, Chaudhari S, Katoch VM, et al. Determination of drug susceptibility patterns and genotypes of Mycobacterium tuberculosis isolates from Kanpur district, North India. Infect Genet Evol. 2011;11(2):469–475. doi:10.1016/j.meegid.2010.12.01021237291
   PubMed Web of Science ®Google Scholar
• Cepheid. GeneXpert diagnosis system GeneXpert MTB/RIF assay manual AND operator manual software version-4. Cepheid. 2012 Available from: https://www.cepheid.com/Package%20Insert%20Files/Xpert-MTB-RIF-ENGLISH-Package-Insert-301-1404-Rev-F.pdf. Accessed 64, 2020.
   Google Scholar
• World Health Organization. Global Tuberculosis Control: A Short Update to the 2009 Report. Geneva: World Health Organization; 2009 Available from: https://apps.who.int/iris/handle/10665/44241. Accessed 64, 2020.
   Google Scholar
• Getahun H, Harrington M, O’Brien R, et al. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet. 2007;369(9578):2042–2049. doi:10.1016/S0140-6736(07)60284-017574096
   PubMed Web of Science ®Google Scholar
• Auld SC, Moore BK, Killam WP, et al. Rollout of Xpert® MTB/RIF in Northwest Cambodia for the diagnosis of tuberculosis among PLHA. Public Health Action. 2014;4(4):216–221. doi:10.5588/pha.14.008226400699
   PubMedGoogle Scholar
• Van Kampen SC, Susanto NH, Simon S, et al. Effects of introducing Xpert MTB/RIF on diagnosis and treatment of drug-resistant tuberculosis patients in Indonesia: a pre-post intervention study. PLoS One. 2015;10(6):e0123536. doi:10.1371/journal.pone.012353626075722
   PubMed Web of Science ®Google Scholar
• Yadav RN, Singh BK, Sharma SK, et al. Correction: comparative evaluatiON of GenotypeMTBDRplus line probe assay with solid culture method in early diagnosis of Multidrug Resistant Tuberculosis (MDR-TB) at a Tertiary Care Centre in India. PLoS One. 2013;8(9):1–6. doi:10.1371/journal.pone.0072036
   Web of Science ®Google Scholar
• Geleta DA, Megerssa YC, Gudeta AN, et al. Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility. BMC Microbiol. 2015;15(1):220. doi:10.1186/s12866-015-0566-626483194
   PubMed Web of Science ®Google Scholar
• Iram S, Zeenat A, Hussain S, et al. Rapid diagnosis of tuberculosis using Xpert MTB/RIF assay-report from a developing country. Pak J Med Sci. 2015;31(1):105–110. doi:10.12669/pjms.311.697025878624
   PubMed Web of Science ®Google Scholar
• Muyoyeta M, Moyo M, Kasese N, et al. Implementation research to inform the use of Xpert MTB/RIF in primary health care facilities in high TB and HIV settings in resource constrained settings. PLoS One. 2015;10(6). doi:10.1371/journal.pone.0126376
   Web of Science ®Google Scholar
• Hordofa MW, Adela TB. Prevalence of rifampicin mono resistant Mycobacterium tuberculosis among suspected cases attending at Yirgalem hospital. Clin Med Res. 2015;4(3):75–78. doi:10.11648/j.cmr.20150403.13
   Google Scholar
• Nigus DM, Lingerew W, Beyene B, et al. Prevalence of multi drug resistant tuberculosis among presumptive multi drug resistant tuberculosis cases in Amhara National Regional State, Ethiopia. J Mycobact Dis. 2014;4(152):2161. doi:10.4172/2161-1068.1000152
   Google Scholar
• Seyoum B, Demissie M, Worku A, et al. Prevalence and drug resistance patterns of Mycobacterium tuberculosis among new smear positive pulmonary tuberculosis patients in eastern Ethiopia. Tuberc Res Treat. 2014;2014.
   Google Scholar
• Derbie A, Worku S, Mekonnen D, et al. Xpert MTB/RIF assay for the diagnosis of Mycobacterium tuberculosis and its Rifampicin resistance at FelegeHiwot and Debre Tabor Hospitals, Northwest Ethiopia: a preliminary implementation research. Ethiop J Health Dev. 2016;30(2):60–66.
   Web of Science ®Google Scholar
• World Health Organization. World Health Organization Global Tuberculosis Report 2013. Geneva, Switzerland: World Health Organization Available from: https://apps.who.int/iris/bitstream/handle/10665/91355/9789241564656_eng.pdf. Accessed 64, 2020.
   Google Scholar
• Zhang Y, Yew WW. Mechanisms of drug resistance in Mycobacterium tuberculosis [State of the art series. Drug-resistant tuberculosis. Edited by CY. Chiang. Number 1 in the series]. Int J Tuberc Lung Dis. 2009;13(11):1320–1330.19861002
   PubMed Web of Science ®Google Scholar
• Torres M, Criado A, Gónzalez N, et al. Rifampin and isoniazid resistance associated mutations in Mycobacterium tuberculosis clinical isolates in Seville, Spain. Int J Tuberc Lung Dis. 2002;6(2):160–163.11931416
   PubMed Web of Science ®Google Scholar
• Hillemann D, Kubica T, Rüsch-Gerdes S, et al. Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany. Antimicrob Agents Chemother. 2005;49(3):1229–1231. doi:10.1128/AAC.49.3.1229-1231.200515728936
   PubMed Web of Science ®Google Scholar
• Lee AS, Lim IH, Tang LL, et al. High frequency of mutations in the rpoB gene in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Singapore. J Clin Microbiol. 2005;43(4):2026–2027. doi:10.1128/JCM.43.4.2026-2027.200515815052
   PubMed Web of Science ®Google Scholar
• Barnard M, Albert H, Coetzee G, et al. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med. 2008;177(7):787–792.18202343
   PubMed Web of Science ®Google Scholar
• Ani AE. Advances in the laboratory diagnosis of Mycobacterium tuberculosis. Ann Afr Med. 2008;7(2):57–61. doi:10.4103/1596-3519.5568019143160
   PubMedGoogle Scholar
• Helb D, Jones M, Story E, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2010;48(1):229–237. doi:10.1128/JCM.01463-0919864480
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Molecular Line Probe Assays for Rapid Screening of Patients at Risk of Multidrug Resistant Tuberculosis (MDR-TB): Policy Statement. Geneva: World Health Organization; 2008 Available from: https://www.who.int/tb/laboratory/line_probe_assays/en/. Accessed 64, 2020.
   Google Scholar
• World Health Organization. Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB. No. WHO/HTM/TB/2013.16. World Health Organization; 2013 Available from: https://apps.who.int/iris/handle/10665/112472. Accessed 64, 2020.
   Google Scholar
• Huang J, Shen M, Sun Y. Epidemiological analysis of extrapulmonary tuberculosis in Shanghai. Zhonghua Jie He He Hu Xi Za Zhi. 2000;23(10):606–608.11372385
   PubMedGoogle Scholar
• Bass JB Jr, Farer LS, Hopewell PC, et al. Diagnostic standards and classification of tuberculosis. Am J Respir Crit Care Med. 1990;142(3):725.
   PubMedGoogle Scholar
• Eisenach KD, Donald Cave M, Bates JH, et al. Polymerase chain reaction amplification of a repetitive DNA sequence specific for Mycobacterium tuberculosis. J Infect Dis. 1990;161(5):977–981. doi:10.1093/infdis/161.5.9772109022
   PubMed Web of Science ®Google Scholar
• Federal Democratic Republic of Ethiopia Ministry of Health/Ethiopian Public Health Institute. Implementation Guideline for GeneXpert MTB/RIF Assay in Ethiopia. Addis Ababa; 2014 Available from: https://www.ephi.gov.et/images/pictures/Implementation%20Guideline%20for%20%20GeneXpert%20MTBRIF%20Assay%20in%20%20Ethiopia%20Nov%2003%202 ....pdf. Accessed 46 2020.
   Google Scholar